Title
Philips Blood Count

Principal / Lead Investigator
Professor Richard Neal (North Wales Centre for Primary Care Research)

Co-Investigators
Julia Hiscock, Rhiannon Tudor Edwards, Rhiannon Whitaker

Start & End date
01/01/2015 – 31/12/2015

Type of study
Qualitative

Lay summary
This study aims to understand what people who are having chemotherapy think of using an innovative piece of technology.  This technology is a small device which allows patients to test their own white blood count at home (or nearby).  If the white blood count is too low then chemotherapy cannot be given.  So testing at home could help prevent unnecessary journeys for patients and wasted appointments for the health service.  This could be especially helpful for patients who live in rural areas and would have a very long journey to the chemotherapy centre, only to be told that they cannot have the chemotherapy that day due to their low blood count.  The study will also explore another way that the device can be helpful, which is to allow patients who are receiving chemotherapy to test their blood count at home if they are feeling unwell.

The aim of this study is to understand the attitudes, experiences and acceptability of using this device.  Because that is what we want to find out, the approach we will use will be to interview people and ask them their views.  We will interview 16 chemotherapy patients who have opted to be in the study and use the device.  We will also interview four cancer doctors and four cancer nurses who have been involved.  As well as the qualitative interviews, we will also collect health economic data to understand not only what people think of using this device, but also how much it costs.

Group role / contribution
School led

Study sponsor
Bangor University

Funder
Tenovus

Total grant value
£29,827